By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters today announced that its board has approved a plan to repurchase up to $500 million of its outstanding common shares over the next 24 months.

The board gave its approval on Wednesday. Purchases will be made through open market transactions. The company recently completed a $500 million stock repurchase program that was announced in February 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.